BioPharmSignal logoBioPharmSignal

Biotech News

Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance

Integra LifeSciences (IART)Integra LifeSciencesEarnings

PRINCETON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Reported revenues were $434.9 million, representing a decrease of 1.7% on

Related news

IARTIntegra LifeSciences2026-07-29 10:00 EST

Integra LifeSciences Reports Second Quarter 2026 Financial Results

IARTIntegra LifeSciences2026-07-16 12:00 EST

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

ACHCAcadia Healthcare2026-07-28 20:05 EST

Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance

ANGOAngioDynamics2026-07-14 10:00 EST

AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability

ANGOAngioDynamics2026-06-30 12:00 EST

AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026

XAIRBeyond Air2026-06-26 11:00 EST

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

MMSIMerit Medical2026-07-30 20:05 EST

Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance

FEMYFEMASYS2026-08-14 20:05 EST

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

PAVMPAVmed2026-08-13 12:00 EST

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

XAIRBeyond Air2026-08-13 11:00 EST

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

View all latest news

Integra LifeSciences

Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and...

Recent company news

IARTIntegra LifeSciences2026-07-29 10:00 EST

Integra LifeSciences Reports Second Quarter 2026 Financial Results

IARTIntegra LifeSciences2026-07-16 12:00 EST

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

IARTIntegra LifeSciences2026-07-02 12:30 EST

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

IARTIntegra LifeSciences2026-06-23 12:00 EST

Integra LifeSciences Announces Key Executive Appointments

IARTIntegra LifeSciences2026-06-15 12:30 EST

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

Stock data

Close
16.74 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States